AlphaHunt
Healthcare

DVA Stock Analysis

DaVita Inc. · current price $210.81 (+0.09% today)

★★★★ Quality 66/ Alpha Score
Solid setup — 3/4 EPS beats. Caveat: trades 8.7% above analyst mean target. Stock is trading above the analyst mean target ($194) — limited consensus headroom.
LAST EARNINGS DaVita Inc. (DVA)

Latest earnings

EPS
$2.95 vs $2.75 est · +0.1% vs estimate BEAT
Revenue
$3.42B · +1.1% YoY
Stock reaction (1M)
+6.2%
Beat streak
3 of last 4 quarters

Key metrics

Alpha Score
66/100
Grade
B
Rev Growth YoY
+6.0%
30-day Momentum
+6.2%
Forward P/E
20.4×
Analyst Target
$193.71
Implied Upside
-8.7%

Latest news on DVA

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA DGX

View all Healthcare stocks →

DVA — frequently asked

What is DVA's Alpha Score?

DaVita Inc. (DVA) currently has a TickerMover Alpha Score of 66/100, rated ★★★★ Quality. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is DaVita Inc. (DVA) a buy?

TickerMover does not give buy or sell recommendations. DVA scores 66/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is DVA's score updated?

DVA's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for DVA →